Pharmaceutical Technology

SEPTEMBER 14, 2022

The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision. Contract marketing of commercial doses.

Marketing 100

Marketing Contract Manufacturing Manufacturing Containment 100

Pharmaceutical Technology

SEPTEMBER 8, 2022

The list of pharmaceutical solid dose manufacturing companies includes providers of solid state and pre-formulation technologies, IND/NDA filing support, technologies for cGMP manufacturing of APIs and intermediates from lab to commercial scale, process optimisation, and designing and developing manufacturing processes.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharmaceutical Technology

SEPTEMBER 15, 2022

The information contained within the download document is intended for manufacturers, suppliers, distributors, pharmaceutical executives, medical representatives, distributors, pharmacists, business development managers, retail salesmen, sales managers, product marketing managers, and any other individual involved in drug injectables marketing.

Marketing 130

Marketing Containment Production Sales 130

Pharmaceutical Technology

SEPTEMBER 14, 2022

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. The advancement in drug design has led to the development of new drug molecules in the form of API peptides and proteins. Technologies in the delivery of peptides and proteins.

Protein 130

Protein Marketing Manufacturing Reagent 130

Pharmaceutical Technology

SEPTEMBER 8, 2022

Large medical and pharmaceutical companies are partnering with small compounding solution providers and research organisations and targeting major compounding pharmacies in regions such as the Asia Pacific to create a sustainable position in the compounding pharmacies market. Test method development.

Marketing 130

Marketing Pharmacy Containment Sales 130

XTalks

MAY 13, 2022

A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. Container Closure Systems. A container closure system protects the product from environmental conditions, safeguarding a product’s purity, strength, safety and efficacy.

Packaging 98

Packaging Packaging Containment Production 98

XTalks

AUGUST 16, 2023

“We knew we had the opportunity to create something special when we saw the positive response to our previous seasonal collaborations for Dunkin’-inspired beers,” said Brian Gilbert, vice president of retail business development at Dunkin’, in a press release. percent between 2022 and 2030. ounce cans.

Branding 52

Branding Containment Marketing Business Development 52

Pharmaceutical Technology

FEBRUARY 16, 2023

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.

Engineer 130

Engineer Manufacturing Containment Production 130

The Pharma Data

OCTOBER 20, 2020

MBA, as the Company’s Chief Business Officer following the retirement of Wenji Chen, PhD, MBA, from her position as Vice President of Corporate Development. Earlier in his career, he ran business-development functions at Amgen and Baxter. Cautionary Note on Forward-Looking Statements. Source link.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

The Pharma Data

MAY 3, 2021

Lilly Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) related to expected dividend payments and potential share repurchases and reflects Lilly ‘s current beliefs and expectations.

Medicine 52

Medicine Containment Business Development Development 52

Drug Discovery World

NOVEMBER 8, 2022

The bioanalytical laboratory will contain 48 workbenches in an open space, with services that include mass spectrometry and ligand binding assays, flow cytometry, biomarkers, as well as cell culture. Contract research organisation (CRO) Emmes has rapidly expanded its capabilities in India during the last two years. .

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

pharmaphorum

OCTOBER 12, 2022

It’s clear that geography and culture impact the research methodologies one must use for effective KOL identification and mapping. It’s essential to add additional identification and mapping research modalities that are able to directly ascertain both the voice of the KOL and the voice of the HCP. Business Development Account Manager.

Marketing 52

Marketing Containment Business Development Research 52

The Pharma Data

NOVEMBER 9, 2020

The trial, conducted in collaboration with the Swiss Group for Clinical Cancer Research (SAKK), will assess the safety, tolerability and anti-tumor activity of IP-001 administered intratumorally following tumor ablation. Contact: Dr. Theresa Visarius Vice President Business Development, Immunophotonics, Inc.

Immune Response 40

Immune Response Clinical Trials Clinical Trials Trials 40

The Pharma Data

NOVEMBER 3, 2020

In addition, LogicBio has a collaboration with Takeda to research and develop LB-301, an investigational therapy leveraging GeneRide for the treatment of the rare pediatric disease Crigler-Najjar syndrome. LogicBio is also developing a Next Generation Capsid platform for use in gene editing and gene therapies.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Editing Genome 52

pharmaphorum

FEBRUARY 11, 2022

Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of rare diseases by providing CZI’s Rare as One Network healthcare data and software. CZI has also partnered with large data collection agencies before.

Life Science 101

Life Science Engineer Development Big Data 101

pharmaphorum

JANUARY 28, 2021

Research also shows that embracing biosimilars and patient choice will lead to the competition needed to further increase access to both biosimilars and biologics for 1.2 The PDPRA is slated for Senate review in 2021; it is aimed at lowering the cost of drugs for patients and contains several provisions that would impact biosimilars.

Marketing 102

Marketing Insulin HR Production 102

The Pharma Data

DECEMBER 17, 2020

George Yeh, President of TLC, commenced the conference and welcomed the company’s new Chief Business Officer, Mr. Tom Bliss. With experiences attained in licensing and business development functions from Amgen, Baxter and Johnson & Johnson, Mr. Bliss introduced himself in Mandarin Chinese. About TLC. Source link.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

The Pharma Data

NOVEMBER 10, 2020

The poster presentation, given by Johan Sandin , CSO at AlzeCure, presents how the mechanisms in the research platform Alzstatin work and shows that the target mechanism within the platform is suitable as a new treatment for Alzheimer’s disease. STOCKHOLM , Nov. About AlzeCure Pharma AB (publ).

Development 40

Development Drugs Protein Research 40

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. “We delivered strong performance this quarter, with volume-driven growth across our core business and most major geographies. on a non-GAAP basis.

Antibody 52

Antibody Sales Production Development 52

The Pharma Data

OCTOBER 27, 2020

is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release.

Sales 52

Sales Production Drug Delivery Development 52

The Pharma Data

JANUARY 4, 2021

Barber is an associate professor of biology and director of the Office of Student Research. Her research focuses on determining the role costimulatory domains play in enhancing chimeric T-cell activity and the creation and testing of the chPD1 receptor as a therapy for multiple types of cancer. Dr. Barber is a tumor immunologist.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. Finally, Thomas attended a panel discussion which asked: ‘What is the next game changer in the CAR T cell field?’

Antibody 59

Antibody Protein Engineer In-Vivo 59

The Pharma Data

MAY 18, 2021

This business developed positively in the Europe/Middle East/Africa region and in Latin America, partly as a result of higher prices, whereas it shrank in North America, in part due to a license expiration. Notes: The following tables contain the key data for the Bayer Group and its divisions for the first quarter of 2021.

Sales 40

Sales Production Marketing Containment 40

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. Their large revenue growth from 2021 to 2022 can be attributed to several significant business development activities in 2022, predominantly acquisitions.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — Sartorius , a leading international partner of life science research and the biopharmaceutical industry, closed the first nine months of 2020 with significant double-digit growth rates in sales revenue and earnings. ” Business development of the Group. Business development of the regions.

Sales 52

Sales Production Life Science Development 52

The Pharma Data

NOVEMBER 5, 2020

The publication presents real-world evidence related to abuse, misuse and diversion of Xtampza ER assessed using Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS ® ) system data sources. This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.

Production 52

Production Marketing Sales Manufacturing 52

The Pharma Data

AUGUST 6, 2020

Research and development expenses increased 90% to $2.5 Research and development expense. The information contained on, or that may be accessed through, our website or social media channels are not incorporated by reference into, and are not a part of, this document. billion in the quarter primarily due to $1.1

Production 52

Production Branding Marketing Licensing 52

The Pharma Data

MAY 4, 2021

Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business (4) in the first three quarters of 2020 , is now included within the Hospital therapeutic area for all periods presented. BNT162b2 (COVID-19 Vaccine) Development Program.

Vaccination 40

Vaccination Vaccine Production Sales 40

The Pharma Data

NOVEMBER 5, 2020

This trial, which is being coordinated by researchers at the University of Oxford , is in patients hospitalized with COVID-19 and will compare the effects of adding REGN-COV2 to the usual standard-of-care versus standard-of-care on its own. Corporate and Business Development Update. Research and development (R&D). $.

Sales 52

Sales Production Manufacturing Antibody 52